May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Isoprostane–induced Inhibition Of [3H]D–aspartate Release From Bovine Isolated Retinae: Role Of Prostanoids
Author Affiliations & Notes
  • C.A. Opere
    Pharmacy Sciences, Creighton University, Omaha, NE
  • A.O. Adeniran
    Pharmacy Sciences, Creighton University, Omaha, NE
  • J. Huang
    Pharmacy Sciences, Creighton University, Omaha, NE
  • W.D. Zheng
    Pharmacy Sciences, Creighton University, Omaha, NE
  • S.E. Ohia
    College of Pharmacy, University of Houston, Houston, TX
  • Footnotes
    Commercial Relationships  C.A. Opere, None; A.O. Adeniran, None; J. Huang, None; W.D. Zheng, None; S.E. Ohia, None.
  • Footnotes
    Support  NIH Grant EY13967
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 433. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.A. Opere, A.O. Adeniran, J. Huang, W.D. Zheng, S.E. Ohia; Isoprostane–induced Inhibition Of [3H]D–aspartate Release From Bovine Isolated Retinae: Role Of Prostanoids . Invest. Ophthalmol. Vis. Sci. 2004;45(13):433.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : We have previously shown that isoprostanes can alter sympathetic neurotransmission in isolated mammalian iris–ciliary bodies (Opere et.al., Free Rad. Res. 35:257, 2001). It is, however, unclear if isoprostanes can also alter amino acid neurotransmission in the mammalian retina. Purpose: In the present study, we evaluated the effect of isoprostanes on K+–induced [3H]D–aspartate release from bovine retinae. We also examined the role of arachidonic acid metabolites on the isoprostane–induced response. Method: Isolated neural retinae were incubated in oxygenated Krebs solution containing 200 nM of [3H]D–aspartate for 60 mins and then prepared for studies of neurotransmitter release using the superfusion method. Release of [3H]D–aspartate was evoked by iso–osmotic concentration of K+ (50 mM) stimuli applied at 90 mins (S1) and at 108 mins (S2) after the onset of superfusion. Results: In the concentration range, 0.1 nM to 10 µM, 8–iso prostaglandin F2ά (8–isoPGF2ά) and 8–iso(15R)PGF2ά caused a concentration–dependent inhibitory effect on K+–evoked [3H]D–aspartate release without affecting basal tritium overflow. For instance, an equimolar concentration (1 µM) of 8–isoPGF2ά and 8–iso(15R)PGF2ά inhibited [3H]D–aspartate release by 32.2% and 20% respectively. Interestingly, the higher concentration of 8–isoPGF2ά (10 µM) had a slight excitatory effect (8%) on [3H]D–aspartate release. Pretreatment of tissues with cyclooxygenase inhibitors, flubiprofen (3 µM) and indomethacin (10 µM) unmasked an inhibitory action of 8–isoPGF2ά (10 µM) on K+–evoked [3H]D–aspartate release. In contrast, the 5–lipoxygenase inhibitor, caffeic acid (10 µM) had no significant effect on the 8–isoPGF2ά –response. Conclusion: Isoprostanes can regulate K+–evoked [3H]D–aspartate release in bovine isolated retinae. Furthermore, prostaglandins may be involved in the effects caused by isoprostanes on excitatory amino acid neurotransmission in the bovine isolated retina.

Keywords: excitatory neurotransmitters • neurotransmitters/neurotransmitter systems • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×